A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma.

M Jablkowski, A Bocian, J Bialkowska… - … of experimental & …, 2005 - europepmc.org
In the present study, the expression of P53 and MDM2 proteins were examined in
specimens from a group of 20 patients (9 with primary hepatocellular carcinoma HCC and …

The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma

SJ Qiu, SL Ye, ZQ Wu, ZY Tang, YK Liu - Journal of cancer research and …, 1998 - Springer
The relationship between mdm2 gene expression and p53 gene mutation in hepatocellular
carcinoma (HCC) and their correlation with the invasiveness of the disease were …

Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features

S Horie, K Endo, H Kawasaki, T Terada - Virchows Archiv, 2000 - Springer
Aberration of the p53 gene is thought to be the most frequent genetic alteration in human
cancers. Tp53 protein may be inactivated by the binding of the MDM2 protein. MDM2, the …

Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

K Endo, T Ueda, T Ohta, T Terada - Liver, 2000 - Wiley Online Library
Background/Aims: The transcription of mdm2 gene is activated by p53 and this limits the
growth‐suppressing activity of p53 by direct binding. It has been reported that MDM2 protein …

Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas

R Broll, A Stark, U Windhövel, R Best, MW Strik… - European Journal of …, 1999 - Elsevier
The aim of our study was to investigate the expression of p53 and mdm2 mRNA and protein
in colorectal adenocarcinoma. For the detection of mRNA, 60 fresh frozen human tumour …

Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance.

D Ofner, H Maier, B Riedmann… - Clinical Molecular …, 1995 - europepmc.org
Aims-To investigate the correlation between the expression of the p53 and mdm-2
oncoproteins and to assess their prognostic value in colorectal cancer. Methods-Using a …

mdm2 gene alterations and mdm2 protein expression in breast carcinomas

A Marchetti, F Buttitta, S Girlando… - The Journal of …, 1995 - Wiley Online Library
This study investigates the mdm2 gene status and expression in 66 surgically resected
human breast carcinomas, with correlations with clinico‐pathological and biological data …

TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas

G Della Torre, G Pasquini, S Pilotti… - Diagnostic Molecular …, 2000 - journals.lww.com
Tumor suppressor protein p53 is a positive regulator of MDM2 gene expression and the
mdm2 protein can bind to p53, preventing the transactivation of p53 responsive genes, thus …

Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.

XP Hao, T Günther, A Roessner, AB Price… - Molecular …, 1998 - ncbi.nlm.nih.gov
AIMS: To evaluate the respective roles of mdm2 (murine double minute 2) and p53 in the
development of colorectal carcinoma. METHODS: Formalin fixed, paraffin wax embedded …

mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations

A Marchetti, F Buttitta, S Pellegrini… - Diagnostic Molecular …, 1995 - journals.lww.com
Fifty-three non-small cell lung carcinomas (NSCLC), previously investigated for p53
abnormalities, were studied to evaluate the status of the mdm2 gene by Southern and …